...
机译:PIK3C3和FGFR的双重抑制作用作为治疗膀胱癌的新治疗方法
Department of Pharmacology School of Medicine College of Medicine Taipei Medical University;
The Ph.D. Program for Cancer Biology and Drug Discovery College of Medical Science and Technology;
Joint Biobank Office of Human Research Taipei Medical University Taipei Taiwan.;
Research Center of Cancer Translational Medicine Taipei Medical University Taipei Taiwan.;
Research Center of Cancer Translational Medicine Taipei Medical University Taipei Taiwan.;
The Ph.D. Program for Cancer Biology and Drug Discovery College of Medical Science and Technology;
Graduate Institute of Translational Medicine Taipei Medical University Taipei Taiwan.;
Department of Pharmacology School of Medicine College of Medicine Taipei Medical University;
Research Center of Cancer Translational Medicine Taipei Medical University Taipei Taiwan.;
Joint Biobank Office of Human Research Taipei Medical University Taipei Taiwan.;
School of Pharmacy College of Pharmacy Taipei Medical University Taipei Taiwan.;
The Ph.D. Program for Cancer Biology and Drug Discovery College of Medical Science and Technology;
机译:PIK3C3和FGFR的双重抑制作用作为治疗膀胱癌的新治疗方法
机译:回复:根治性膀胱切除术后微乳头状尿路上皮癌患者的结果:ERBB2(HER2)扩增可确定结果较差的患者基础的选择性膀胱保留方法社论评论
机译:ERBB2过表达在基于化学放射治疗的选择性膀胱保留方法治疗的肌肉浸润性膀胱癌患者中的耐药性和癌症特异性生存的意义
机译:麻醉大鼠隐神经的电刺激:一种治疗膀胱过度活动症的新治疗方法
机译:BEZ235对PI3K / mTOR的双重抑制作用增强了阿霉素在癌症中的治疗效果,而不会影响心脏功能。
机译:鳞状分化膀胱癌中的成纤维细胞生长因子受体(FGFR)改变:一个小亚组的假定治疗靶标
机译:PIK3C3和FGFR的双重抑制作用作为治疗膀胱癌的新治疗方法
机译:抑制突变:一种预防和治疗癌症的新方法